561 related articles for article (PubMed ID: 28058861)
1. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
4. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
5. Claudin-4 is required for vasculogenic mimicry formation in human breast cancer cells.
Cui YF; Liu AH; An DZ; Sun RB; Shi Y; Shi YX; Shi M; Zhang Q; Wang LL; Feng Q; Pan GL; Wang Q
Oncotarget; 2015 May; 6(13):11087-97. PubMed ID: 25871476
[TBL] [Abstract][Full Text] [Related]
6. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma.
Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A
Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555
[TBL] [Abstract][Full Text] [Related]
7. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
9. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
10. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
Yeo C; Lee HJ; Lee EO
Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
[TBL] [Abstract][Full Text] [Related]
11. Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
Maroufi NF; Rashidi M; Vahedian V; Jahanbazi R; Mostafaei S; Akbarzadeh M; Kazemzadeh H; Nejabati HR; Isazadeh A; Rashidi MR; Nouri M
Breast Cancer; 2022 Mar; 29(2):260-273. PubMed ID: 34725795
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
Yeo C; Han DS; Lee HJ; Lee EO
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
[TBL] [Abstract][Full Text] [Related]
13. N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.
Pagano C; Navarra G; Pastorino O; Avilia G; Coppola L; Della Monica R; Chiariotti L; Florio T; Corsaro A; Torelli G; Caiazzo P; Gazzerro P; Bifulco M; Laezza C
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638872
[TBL] [Abstract][Full Text] [Related]
14. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
Han DS; Lee EO
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
[TBL] [Abstract][Full Text] [Related]
15. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
Fan X; Huang J; Hu B; Zhou J; Chen L
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
Liu W; Lv C; Zhang B; Zhou Q; Cao Z
RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
[TBL] [Abstract][Full Text] [Related]
17. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells.
Lim D; Cho JG; Yun E; Lee A; Ryu HY; Lee YJ; Yoon S; Chang W; Lee MS; Kwon BS; Kim J
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374832
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
Li Y; Wu Z; Yuan J; Sun L; Lin L; Huang N; Bin J; Liao Y; Liao W
Cancer Lett; 2017 Jun; 395():31-44. PubMed ID: 28268166
[TBL] [Abstract][Full Text] [Related]
20. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
Hori A; Shimoda M; Naoi Y; Kagara N; Tanei T; Miyake T; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res; 2019 Aug; 21(1):88. PubMed ID: 31387614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
